NSE · BETA
Beta Drugs Limited
₹2,595.20
+1.41%
Market Cap
2,630.70 Cr
P/E Ratio
63.42
P/B Ratio
10.75
ROE
16.95%
ROCE
17.98%
Dividend Yield
—
52W High
₹2,807.90
52W Low
₹1,450.20
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 125.55 Cr | 93.96 Cr |
| Net Profit | 16.49 Cr | 9.05 Cr |
| EPS | 14.78 | 8.93 |
| Operating Profit | 24.60 Cr | 15.78 Cr |
Shareholding pattern
Promoter
59.10%
Public
40.90%
FII
—
DII
—
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.